LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Severe thrombocytopenia as a predictor of survival and response to hypomethylating agents in myelodysplastic syndromes: A Latin‐American cohort of 212 patients

Photo by nci from unsplash

AUTHOR CONTRIBUTIONS Contribution: K.B.B.P., principal investigator of this trial, conceived and designed the study; E.V.D.P., M.T.D. and G.O.D. were sub-investigators. KBBP and EVDP contributed to the data interpretation and drafted… Click to show full abstract

AUTHOR CONTRIBUTIONS Contribution: K.B.B.P., principal investigator of this trial, conceived and designed the study; E.V.D.P., M.T.D. and G.O.D. were sub-investigators. KBBP and EVDP contributed to the data interpretation and drafted the manuscript. K.B.B.P., E.V.D.P., A.B.P.L., E.C.M., C.D.S. contributed to critical review and revision of the manuscript. ECM made the statistical analysis. A.B.P.L., M.T.D., G.O.D., J.V., M.A.S.S. participated in the site work, including the recruitment, follow-up, and data collection. A.B.P.L., B.R.V.R., V.M.O.P. and G.C.P.F. performed laboratory analyses. All authors approved the final version of the final manuscript and were responsible for the decision to submit for publication.

Keywords: thrombocytopenia predictor; predictor survival; severe thrombocytopenia; survival response; hypomethylating agents; response hypomethylating

Journal Title: American Journal of Hematology
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.